A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...
Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has introduced the ISG Supplier Risk Exposure Scorecard™, which evaluates enterprise-wide ...
A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.
A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
Helcim, a Canadian payments company that helps small businesses accept cards and manage transactions, has implemented an AI-powered risk scorecarding system to improve how it approves and monitors ...
Incorporating a polygenic risk score into prostate cancer screening could enhance the detection of clinically significant prostate cancer that conventional screening may miss, according to results of ...
Equifax has announced the launch of its fourth generation Bankruptcy Navigator Index (BNI) score, its most comprehensive and predictive bankruptcy risk score ever. With BNI 4.0, lenders can make more ...
MOORESTOWN, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces the journal Pharmacy has ...
A polygenic risk score (PRS) may help identify women who are at a greater risk of developing a future breast cancer after treatment for in situ breast disease, a retrospective study suggests. The ...
Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...
Risk Score Model of Aging-Related Genes for Bladder Cancer and Its Application in Clinical Prognosis
Transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus were used to construct a 12-gene ARG-based prognostic signature through LASSO and Cox regression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results